Offer - Urjas Oil for just ₹ 1 X
Erbitux 500 Infusion is a prescription drug, available for use as Injection. Colorectal Cancer are some of its major therapeutic uses. Secondary and off-label uses of Erbitux 500 Infusion have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Erbitux 500 Infusion. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Erbitux 500 Infusion include Nausea or vomiting, Headache, Skin Rash. Apart from the aforementioned side effects, Erbitux 500 Infusion can also lead to other problems, which have been listed below. These side effects of Erbitux 500 Infusion are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Erbitux 500 Infusion's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Erbitux 500 Infusion's effects on the liver, heart and kidney, if any, have been listed below.
Erbitux 500 Infusion is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Calcium Deficiency, Potassium Deficiency are examples of such conditions. Other contraindications of Erbitux 500 Infusion have been discussed in the sections ahead.
Drug reaction of Erbitux 500 Infusion with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Erbitux 500 Infusion is considered not safe while driving, and is not addictive.
Erbitux 500 Infusion is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Erbitux 500 Infusion safe for pregnant women?
Erbitux should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Erbitux 500 Infusion safe during breastfeeding?
Erbitux may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Erbitux 500 Infusion on the Kidneys?
Erbitux does not damage the kidneys.
What is the effect of Erbitux 500 Infusion on the Liver?
Erbitux is not harmful for the liver.
What is the effect of Erbitux 500 Infusion on the Heart?
The heart can be affected by Erbitux. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Erbitux 500 Infusion unless your doctor advises you to do so -
Is this Erbitux 500 Infusion habit forming or addictive?
No, there is no any evidence that Erbitux 500 Infusion is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Erbitux 500 Infusion, you should not drive or work on any heavy machine, as Erbitux 500 Infusion can make you drowsy.
Is it safe?
Yes, Erbitux 500 Infusion is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Erbitux 500 Infusion is not used to treat mental disorders.
Interaction between Food and Erbitux 500 Infusion
Taking Erbitux 500 Infusion with food does not harm your health.
Interaction between Alcohol and Erbitux 500 Infusion
Information about the interaction of Erbitux 500 Infusion and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Erbitux® (cetuximab)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 317-319